MOMETASONE FUROATE MONOHYDRATE

Aurobindo Pharma Limited🇺🇸 United States

FDA Page

Effective Date: Mar 19, 2024
Approval ID: b24f80c5-afe2-4821-9185-2dad3cfe277a
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MOMETASONE FUROATE MONOHYDRATE NASAL SPRAY safely and effectively. See full prescribing information for MOMETASONE FUROATE MONOHYDRATE NASAL SPRAY. MOMETASONE FUROATE MONOHYDRATE nasal spray Initial U.S. Approval: 1997

Quick Stats

Total Products1

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.